Typhim Vi Injection, Solution
Product Images NDC 49281-790

7 FDA label images from Sanofi Vaccines Us Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Typhim Vi (NDC 49281-790). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Vaccines Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Picture A (Typhim 01)

Picture A (Typhim 01)
An instructional illustration showing a syringe with labeled parts: syringe plunger, syringe barrel, tip cap, and syringe cap. Arrows indicate these components, and a curved arrow shows the direction to remove the syringe cap.*
FDA Label Image

Figure (Typhim 02)

Figure (Typhim 02)
An instructional line drawing illustrating hands preparing an injection syringe by twisting or removing the cap from the needle or syringe end, as part of administering a vaccine injection.*
FDA Label Image

Figure (Typhim 03)

Figure (Typhim 03)
An instructional illustration showing hands removing a protective cap from the tip of a syringe, with arrows indicating the direction to pull and twist the cap off. This likely demonstrates preparation steps for an injection.*
FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

Principal Display Panel (0.5 mL Syringe Label)
Label for Typhim Vi Polysaccharide Vaccine (Salmonella Typhi Ty2 Vi Polysaccharide Antigen) injection, solution, single-dose 0.5 mL. The label indicates intramuscular use only and prescription use only. The product is manufactured by Sanofi Pasteur. The label includes a barcode and space for lot, expiration date, and a 2D barcode.*
FDA Label Image

Principal Display Panel (0.5 mL Syringe Package)

Principal Display Panel (0.5 mL Syringe Package)
Typhim Vi 25 mcg/.5 mL Typhoid Vi Polysaccharide Vaccine injection, solution in a single-dose prefilled syringe. The label indicates intramuscular administration, storage at 2° to 8°C, and warnings against freezing. Manufactured by Sanofi Pasteur SA and distributed by Sanofi Pasteur Inc. The packaging includes dosage information and preservative details.*
FDA Label Image

Principal Display Panel (20 Dose Vial Label)

Principal Display Panel (20 Dose Vial Label)
Label for Typhoid Vi Polysaccharide Vaccine – Typhim Vi, a multi-dose vial (20 doses) for intramuscular injection. The label shows storage instructions (2° to 8°C, do not freeze), manufacturer as Sanofi Pasteur SA, and distributor as Sanofi Pasteur Inc., Swiftwater, PA. Includes barcode and statement indicating Rx only.*
FDA Label Image

Principal Display Panel (20 Dose Vial Package)

Principal Display Panel (20 Dose Vial Package)
Typhim Vi 25 ug/.5mL injection, solution multi-dose vial carton label for Typhoid Vi Polysaccharide Vaccine by Sanofi Pasteur. The label includes administration instructions for intramuscular use, storage guidelines, and NDC 49281-790-20. The packaging indicates a multi-dose vial containing 20 doses and features barcodes, manufacturer information, and warnings about vaccine clarity and freezing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.